Vivex Biologics Publishes Promising Study on Long-term Outcomes of VIA Form+ in Spinal Fusion Vivex Biologics, Inc. has unveiled a significant peer-reviewed study showcasing the effectiveness of VIA Form+ in lumbar spinal fusion surgeries, noting impressive outcomes over three years.

Vivex Biologics Publishes Promising Study on Long-term Outcomes of VIA Form+ in Spinal Fusion #United_States #Miami #spinal_fusion #Vivex_Biologics #VIA_Form+

Jim Hens Joins Providence Medical Technology as CCO Amidst Growth Providence Medical Technology has announced Jim Hens as its new Chief Commercial Officer, aimed at driving growth after a groundbreaking study on spinal fusion.

Jim Hens Joins Providence Medical Technology as CCO Amidst Growth #USA #Pleasanton #spinal_fusion #Providence_Medical #Jim_Hens

SynerFuse™ and Velentium Medical Expand Innovative Spinal Fusion Procedures SynerFuse™ collaborates with Velentium Medical to enhance spinal fusion techniques with integrated nerve stimulation, offering new hope for patients.

SynerFuse™ and Velentium Medical Expand Innovative Spinal Fusion Procedures #United_States #Eden_Prairie #SynerFuse™ #Velentium_Medical #spinal_fusion